UNCY - Unicycive Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

UNCY is currently covered by 2 analysts with an average price target of $8.43. This is a potential upside of $4.18 (98.35%) from yesterday's end of day stock price of $4.25.

Unicycive Therapeutics's activity chart (see below) currently has 13 price targets and 32 ratings on display. The stock rating distribution of UNCY is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 77.14% with an average time for these price targets to be met of 700.75 days.

Highest price target for UNCY is $7.5, Lowest price target is $7.5, average price target is $7.5.

Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 11-Apr-2025. First documented stock forecast 09-Aug-2021.

Best performing analysts who are covering UNCY - Unicycive Therapeutics:

Elemer Piros Ed Arce Jason Mccarthy Bruce Jackson

Currently out of the existing stock ratings of UNCY, 18 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$7.5

$2.8 (59.57%)

$7.5

4 months 10 days ago
(11-Apr-2025)

2/7 (28.57%)

$6.95 (1263.64%)

424

Buy

8 months 30 days ago
(22-Nov-2024)

4/4 (100%)

$2.09 (229.67%)

584

Buy

$5

$0.3 (6.38%)

$5

2 years 1 months 22 days ago
(30-Jun-2023)

4/5 (80%)

$3.72 (290.63%)

782

Buy

$6

$1.3 (27.66%)

$3

2 years 5 months 12 days ago
(09-Mar-2023)

2/2 (100%)

$3.94 (191.26%)

1013

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is UNCY (Unicycive Therapeutics) average time for price targets to be met?

On average it took 700.75 days on average for the stock forecasts to be realized with a an average price target met ratio 77.14

Which analyst has the current highest performing score on UNCY (Unicycive Therapeutics) with a proven track record?

ELEMER PIROS

Which analyst has the current lower performing score on UNCY (Unicycive Therapeutics) with a proven track record?

BRUCE JACKSON

Which analyst has the most public recommendations on UNCY (Unicycive Therapeutics)?

Elemer Piros has 6 price targets and 6 ratings on UNCY

Which analyst is the currently most bullish on UNCY (Unicycive Therapeutics)?

Ed Arce with highest potential upside - $2.8

Which analyst is the currently most reserved on UNCY (Unicycive Therapeutics)?

Bruce Jackson with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?